Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Daiichi Sankyo
Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Astellas
FDA
gilteritinib
Europe
AML
Daiichi Sankyo
Daiichi Sankyo to cut 69 opioid sales jobs
Beckers Hospital Review
Tue, 08/13/19 - 10:26 am
Daiichi Sankyo
opioids
layoffs
drug reps
Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions
Endpoints
Mon, 08/5/19 - 11:32 am
Daiichi Sankyo
FDA
pexidartinib
Turalio
tenosynovial giant cell tumors
FDA declines to approve Daiichi Sankyo's blood cancer treatment
Reuters
Fri, 06/21/19 - 11:55 pm
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Motley Fool
Wed, 06/12/19 - 09:45 am
Vertex Pharmaceuticals
VX-445
tezacaftor/ivacaftor
AbbVie
upadacatinib
Daiichi Sankyo
trastuzumab deruxtecan
Celgene
liso-cel
Novartis
LY3298176
Daiichi Sankyo Denies Report That It's Selling Over-the-Counter Drug Unit
BioSpace
Fri, 05/24/19 - 10:40 am
Daiichi Sankyo
OTC
Daiichi Sankyo in talks over OTC unit sale – reports
Pharmaforum
Thu, 05/23/19 - 09:56 am
Daiichi Sankyo
M&A
OTC
Daiichi Sankyo comes up way short of promised avian flu vaccine production
Fierce Pharma
Wed, 05/22/19 - 08:34 pm
Daiichi Sankyo
vaccines
Japan
avian flu
drug shortages
Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No
BioSpace
Wed, 05/15/19 - 11:42 am
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
pexidartinib
TGCT
FDA questions credibility of Daiichi data ahead of AdComm
Fierce Biotech
Mon, 05/13/19 - 09:32 am
FDA
Daiichi Sankyo
quizartinib
acute myeloid leukemia
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sat, 05/11/19 - 12:31 pm
biotech
Achillion
Sesen Bio
The Medicines Company
Amgen
Daiichi Sankyo
earnings
AstraZeneca's share dilution gamble on Daiichi drug pays off
Biopharma Dive
Thu, 05/9/19 - 10:49 am
AstraZeneca
Daiichi Sankyo
trastuzumab deruxtecan
metastatic breast cancer
AZ and Daiichi to file new breast cancer drug after trial success
Pharmaforum
Wed, 05/8/19 - 10:05 am
AstraZeneca
Daiichi Sankyo
trastuzumab deruxtecan
antibody-drug conjugate
Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks
Fierce Biotech
Thu, 04/25/19 - 11:45 am
Daiichi Sankyo
immuno-oncology
Zymeworks
bispecific antibodies
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
Yahoo/Reuters
Fri, 03/29/19 - 10:06 am
AstraZeneca
Daiichi Sankyo
breast cancer
trastuzumab deruxtecan
Doubling down on R&D, Daiichi makes executive changes across its U.S. research unit
Fierce Biotech
Fri, 02/22/19 - 11:46 am
R&D
Daiichi Sankyo
Daiichi gets speedy FDA review for rare cancer drug
Pharmaforum
Fri, 02/8/19 - 09:38 am
Daiichi Sankyo
FDA
pexidartinib
TGCT
priority review
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Sat, 01/12/19 - 11:30 am
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
Daiichi Sankyo lines up a $900M deal for rights to a cholesterol drug looking to disrupt a blockbuster market
Endpoints
Fri, 01/4/19 - 09:20 am
Daiichi Sankyo
Esperion Therapeutics
Daiichi Sankyo signs clinical trial collaboration deal with Merck and Pfizer
Pharmaceutical Business Review
Fri, 10/26/18 - 09:52 am
Daiichi Sankyo
Merck
Pfizer
clinical trials
DS-8201
solid tumors
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »